Change in Long-Spacing Collagen in  
                        Descemet's Membrane of Diabetic Goto-Kakizaki Rats  
                        and Its Suppression by Antidiabetic Agents by Akimoto, Yoshihiro et al.
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2008, Article ID 818341, 8 pages
doi:10.1155/2008/818341
ResearchArticle
Change in Long-Spacing Collagen in
Descemet’s Membrane of Diabetic Goto-Kakizaki Rats
and Its Suppression by Antidiabetic Agents
YoshihiroAkimoto,1 HajimeSawada,2 MicaOhara-Imaizumi,3 ShinyaNagamatsu,3 andHayatoKawakami1
1Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo 181-8611, Japan
2Department of Anatomy, Yokohama City University School of Medicine, Kanazawa Ku, Fukuura 3-9, Yokohama,
Kanagawa 236-0004, Japan
3Department of Biochemistry, Kyorin University School of Medicine, Mitaka, Tokyo 181-8611, Japan
Correspondence should be addressed to Yoshihiro Akimoto, yakimoto@kyorin-u.ac.jp
Received 24 January 2008; Revised 23 April 2008; Accepted 1 July 2008
Recommended by Timothy Kern
We examined changes in the ultrastructure and localization of major extracellular matrix components, including 5 types of
collagen (type I, III, IV, VI, and VIII), laminin, ﬁbronectin, and heparan sulfate proteoglycan in Descemet’s membrane of the
cornea of diabetic GK rats. In the cornea of diabetic GK rats, more long-spacing collagen ﬁbrils were observed in Descemet’s
membranethaninthemembraneofthenondiabeticWistarrats.BothGKandWistarratsshowedanage-dependentincreaseinthe
density of the long-spacing collagen. Immunoelectron microscopy showed that type VIII collagen was localized in the internodal
region of the long-spacing collagen, which was not labelled by any of the other antibodies used. The antidiabetic agents nateglinide
and glibenclamide signiﬁcantly suppressed the formation of the long-spacing collagen in the diabetic rats. Long-spacing collagen
would thus be a useful indicator for studying diabetic changes in the cornea and the eﬀect of antidiabetic agents.
Copyright © 2008 Yoshihiro Akimoto et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Corneal keratopathy is one of the diabetic complications.
Clinically, the diabetic cornea often shows superﬁcial punc-
tate keratopathy and persistent epithelial defects and recur-
rent epithelial erosion that are considered to be a form of
diabetic keratoepitheliopathy. Various degrees of epithelial
disturbance take place in the diabetic cornea. Thickening
of epithelial basement membrane in the diabetic cornea
has been extensively studied [1, 2] .I nap r e v i o u ss t u d y ,w e
showed that hemidesmosomes in the epithelial basal cells
were decreased in number in the diabetic rats and that the
basement membrane detached from the epithelial basal cells
[3]. Also, the content of O-GlcNAc-modiﬁed proteins was
found to be increased in the corneal epithelium as well as in
the nerves, kidneys, and pancreas of diabetic rats [3–5].
The diabetic corneal endothelium has been shown by
speculum-aided microscopy to have morphological abnor-
malities such as polymorphism [6]. The endothelial cells
vary in cell shape and in cell area in the diabetic rat and
human cornea [7, 8]. At the posterior side of the cornea, a
thick basement membrane called Descemet’s membrane is
located adjacent to the endothelium. In the normal human
cornea, long-spacing collagen, which is cross-striated ﬁber
bundle, is located only in the anterior-banded zone of
Descemet’s membrane [9, 10]. However, in the cornea of
normal Sprague-Dawley rats, there is no such collagen in
Descemet’s membrane [11]. Although the normal rat and
human Descemet’s membranes diﬀer in this regard, in the
corneas of both diabetic human patients and Streptozotocin-
induced diabetic rats, unusual long-spacing collagen was
observed scattered in Descemet’s membrane [11, 12].
The spontaneously diabetic Goto-Kakizaki (GK) rat is
a nonobese model of type 2 diabetes that was developed
by the selective breeding of glucose-intolerant Wistar rats
[13–15]. In the eyes of GK rats, various abnormalities have
been reported, including decreased retinal microcirculation
[15], elevated levels of vascular endothelial growth factor
[16], nitric oxide synthase activity in the retina [17],
delayed wound closure, as well as phenotypic changes in the2 Experimental Diabetes Research
corneal epithelium [18]. However, little attention has been
paid to Descemet’s membrane in GK rats. To investigate
Descemet’s membrane in terms of the pathogenesis of
diabetes mellitus, in the present study we examined the
ultrastructural morphology, and immunohistochemically
determined the composition of Descemet’s membrane in
the cornea of diabetic GK rats in comparison with normal
Wistar rats. Furthermore, we examined if the morphological
change detected could be prevented by antidiabetic agents.
Our ﬁndings revealed that unusual long-spacing collagen
appeared and increased in content rapidly with aging in
the Descemet’s membrane of the diabetic rat cornea, and
that its appearance could be suppressed by the antidiabetic
agents.
2. MATERIALS AND METHODS
2.1. Animalsandtissues
All experimental procedures using laboratory animals were
approved by the Animal Care and Use Committee of Kyorin
University School of Medicine. The corneas of 15-, 33-,
and 62-week-old male (n = 6 for each age) Goto-Kakizaki
rats and Wistar rats (as normal controls), obtained from
Kurea (Tokyo, Japan), were used in the present study. Rats
were housed under 12-hour light: 12-hour dark cycle and
given free access to food and water. Serum glucose levels in
Wistar and GK rats, which were measured after an overnight
fast, were, respectively, 158.0 ± 12.0 and 375.9 ± 11.6
(mean ± SEM) mg/dL at 15 weeks, 118.5 ± 10.5a n d
333.8 ± 22.4mg/dL at 33 weeks, and 167.0 ± 28.6a n d
314.9 ± 48.7mg/dL at 62 weeks. As reported previously [5],
serum insulin levels were also higher in the GK rats.
2.2. Antibodies
A monoclonal antibody (clone 9H3) against Type VIII
collagen and a monoclonal antibody (clone 15B6) against
Type VI collagen were prepared and characterized as
described previously [19, 20]. Polyclonal antibody against
laminin and type IV collagen were purchased from EY
laboratory (San Meteo, Calif, USA) and LSL (Tokyo, Japan),
respectively. Monoclonal antibody against heparan sulfate
proteoglycan and ﬁbronectin were purchased from Upstate
Biotechnology (Lake Placid, NY, USA) and Chemicon
International(Temecula,Calif,USA),respectively.Alexa568-
conjugated donkey anti-rabbit or mouse IgG and SYBR-
Green I were obtained from Molecular Probes (Eugene, Ore,
USA).
2.3. Immunohistochemicallocalization
Immunoﬂuorescence observation for localization of com-
ponents of extracellular matrix was performed as described
earlier [21]. Corneas were ﬁxed in 4% paraformaldehyde
in 0.1M phosphate buﬀer (pH7.3) for 1 hour at 4◦C.
After having been washed with PBS, the specimens were
embedded in OCT compound (Miles; Elkhart, Ill, USA).
Frozen sections (4μm thick) were made, washed with PBS,
and incubated for 10 minutes in 5% BSA in PBS. The
sections were then incubated with anti-extra-cellular matrix
component antibody for 1 hour at room temperature,
washed with PBS, and subsequently incubated with Alexa
568-conjugated donkey anti-rabbit or mouse IgG antibody
(1:200). Nuclei were stained with SYBR-Green I (1:500).
After a ﬁnal wash with PBS, the specimens were mounted
in 90% glycerol-0.1M Tris-HCl buﬀer (pH8.5) containing
0.5mM p-phenylene diamine, and observed under a laser
scanning confocal microscope (LSM510, Zeiss, Mass, USA).
For a control experiment, the specimens were incubated
with normal rabbit or mouse IgG or with 0.1% BSA-
PBS alone instead of the primary antibodies. No positive
staining was observed in the control experiment (data not
shown).
2.4. Electronmicroscopy
Corneas were ﬁxed in phosphate-buﬀered 2.5% glutaralde-
hyde (pH7.4). Strips of cornea were taken from the central
part of the cornea, and were postﬁxed in 1% OsO4 in
0.1Mphosphatebuﬀer(pH7.4),anddehydratedwithgraded
alcohols. After immersion in propylene oxide, the specimens
were embedded in Epon 812. Ultrathin sections were cut
perpendicular to the epithelium, doubly stained with uranyl
acetate and lead citrate, and examined with a transmission
electron microscope, TEM-1010 (JEOL, Tokyo, Japan).
2.5. Immunoelectronmicroscopy
Immunoelectron microscopic observation for localization
of components of extracellular matrix was performed as
described earlier [22]. Fixation was carried out in the same
way as for light microscopy. Ultrathin frozen-sections were
cut at −90 to −100
◦C. The sections were washed with
PBS and pretreated with 1% BSA in PBS for 10 minutes.
After a PBS rinse, they were incubated with the desired
antibodies for 1 hour, washed with PBS, and incubated
withcolloidalgold-conjugatedgoatanti-rabbitormouseIgG
antibodies for 1 hour. After another wash with PBS, the
sections were reﬁxed in 2% glutaraldehyde-0.1M phosphate
buﬀer,pH7.4,andembeddedinamixtureofmethylcellulose,
polyethyleneglycol, and uranyl acetate.
2.6. Antidiabeticagentsandexperimentaldesign
The administration of antidiabetic drugs was started at
8 weeks old. Nateglinide (50mg/kg) or glibenclamide
(2mg/kg) was suspended in 0.5% methylcellulose and
administered to GK rats via a stomach tube in volume of
10mL/kg [23–25]. These doses of the antidiabetic agents
were chosen from the data on their suppressive eﬀects on the
peakbloodglucoselevelsafteroralsucroseorglucoseloading
of fasted normal rats for 15 weeks [23, 26]. GK rats were
fed twice daily (9:00 and 16:00) for 1 hour and were given
nateglinide or glibenclamide orally just before each meal.
Control rats were treated with 0.5% methylcellulose alone
(the vehicle).Yoshihiro Akimoto et al. 3
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Figure 1: Electron microscopic image of long-spacing collagen
present in Descemet’s membrane of a diabetic GK rat. Arrow
indicates a rod-like structure in the internodal region. Scale bar,
100nm.
2.7. Statisticalanalysis
Results were expressed as the mean ± standard deviation,
and the statistical analysis was done by the use of the
unpaired Student’s t-test. Diﬀerences were deﬁned as signiﬁ-
cant at P<. 05.
3. RESULTS
3.1. Changesinultrastructuralmorphologyof
Descemet’smembraneinthecorneaofdiabetic
andnormalratswithaging
The ultrastructure of Descemet’s membrane in the cornea
in 15-, 33-, and 62-week-old diabetic and nondiabetic rat
corneas was examined by electron microscopy. The thickness
of the membrane remained unchanged in both groups.
In the 15-week-old rat cornea, abnormal collagen ﬁbril
bundles (long-spacing collagen) were frequently observed
in Descemet’s membrane of diabetic rats, whereas they
were observed less so in that of the normal rats. Figure 1
shows electron microscopic images of the long-spacing
collagen. The banding pattern was wide, averaging 110–
120nm. A rod-like structure was observed in the internodal
region of typical long-spacing collagen (Figure 1). The size
and number of long-spacing collagen molecules increased
with aging in both the normal and diabetic Descemet’s
membrane (Figures 2 and 3). At 62 weeks, the average
length of the long-spacing collagen was 0.25–1.0μmi n
normal rats and 0.5–2.15μm in the diabetic ones. In the
diabetic cornea, the number of long-spacing collagen ﬁbrils
in the membrane increased more than in the normal cornea
with aging. The density of these collagen ﬁbrils was higher
adjacent to the endothelium and lower toward the stroma
(Figure 2).
3.2. Immunohistochemicallocalization
oftypeVIIIcollagen
It was earlier shown that type VIII collagen is localized in
Descemet’s membrane [19]. So we examined the localization
of type VIII collagen in the rat cornea by laser confocal
scanning microscopy (Figure 4). Whereas weak staining was
observed in Descemet’s membrane of the normal cornea,
more intense punctate staining was observed in that of the
diabetic one (Figure 4).
3.3. Immunoelectronmicroscopiclocalization
oftypeVIIIcollagen
Localization of type VIII collagen in Descemet’s membrane
was examined immunoelectron-microscopically by using
the colloidal-gold labeling method (Figure 5). In the nor-
mal cornea, the colloidal gold was detected diﬀusely in
Descemet’s membrane (Figure 5(a)). In the diabetic cornea,
however, it was found in the region between bands of
the long-spacing collagen (Figure 5(b)). This localization
of type VIII collagen in the diabetic rat is consistent with
that reported previously for the diseased human Descemet’s
membrane [9, 10].
3.4. Localizationofothercomponentsof
extracellularmatrix
Next we examined the localization of the other components
of the extracellular matrix, that is, laminin and type I,
III, IV, and VI collagens. There is a report that type VI
collagen becomes localized in the long-spacing collagen
in the corneoscleral meshwork of human eyes [27]. So
weexaminedimmunoelectron-microscopicallywhethertype
VI collagen could also be detected in the long-spacing
collagen of Descemet’s membrane. In both the normal and
diabetic cornea, the colloidal gold label was mostly seen
in the corneal stroma; but none was detected in either
Descemet’s membrane or in the long-spacing collagen of
this membrane (Figure 6). Collagens type I and III showed
the same distribution as the type VI (data not shown).
Laminin (Figure 7) and type IV collagen (data not shown)
were localized in the amorphous material of Descemet’s
membrane,butwerenotpresentinthelong-spacingcollagen
in neither the normal nor diabetic cornea.
3.5. Effectofantidiabeticagentsonthe
formationoflong-spacingcollagen
The morphological change in long-spacing collagen is
thought to be one of the complications of diabetes. Thus
we examined whether the abnormal formation of long-
spacing collagen could be suppressed by the antidiabetic
agents nateglinide and glibenclamide. As shown in our
previous study [25], during the period of antidiabetic agent
treatments, there was no diﬀerence in fasting blood glu-
cose levels among vehicle-treated, nateglinide-treated, and
glibenclamide-treated GK rat. Nateglinide administration
reduced blood glucose levels 1 hour after feeding, whereas
glibenclamide reduced blood glucose levels 2 and 3 hours
after feeding, but not 1 hour after feeding [25]. Although
the degree of the antidiabetic eﬀect was diﬀerent between the
2 agents, both of them signiﬁcantly (P<. 05) inhibited the
formation of the long-spacing collagen in the diabetic GK
rats (Figure 8). Glibenclamide treatment was more eﬀective
than nateglinide treatment (Figure 8).4 Experimental Diabetes Research
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Figure 2: Electron micrographs of Descemet’s membrane of Wistar (a), (b), (c) and GK (d), (e), (f) rat corneas at 15 (a), (d), 33 (b), (e),
and 62 (c), (f) weeks. Long-spacing collagen (arrowheads) accumulates with increasing age. Dm: Descemet’s membrane; En: endothelium;
S: stroma. Scale bar: 500nm.
4. DISCUSSION
Our present study revealed that a diabetes-associated
increase in the number of long-spacing collagen ﬁbrils
occurred in Descemet’s membrane in the cornea of type II
diabetes model GK rats. This result is consistent with the
ﬁndings made in the corneas of diabetic humans and type I
diabetesmodelStreptozotocin-induceddiabeticrats[11,12].
The long-spacing collagen was much more abundant in the
diabetic cornea than in the nondiabetic one, and it increased
with aging in both the nondiabetic Wistar and diabetic GK
rats (Figures 2 and 3). These results reveal that the age-
associated morphological change in Descemet’s membrane
was accelerated by diabetes.
Immunoelectron microscopy showed that the long-
spacing collagen contained type VIII collagen molecules
(Figure 5). However, antibodies against type I, III, IV, or VI
collagen did not bind to the long-spacing collagen. These
results are consistent with those obtained from human and
bovine Descemet’s membrane [28, 29]. Type VIII collagen
was found as a product of rabbit corneal and bovine aortic
endothelial cells [30, 31]. Type VIII collagen is a major
constituent of the hexagonal lattice of Descemet’s membrane
[19]. Descemet’s lattice collagen can assemble into other
long-spacing ﬁbrils with a longer periodicity [19]. It is
thought that the function of type VIII collagen is to provide
an open, porous structure that can withstand compressive
force [19]. Under some special condition of the diabetic
state, type VIII collagen may contribute to the assembly of
these unusual long-spacing collagen ﬁbrils. It was earlier
postulatedthattheaggregatesofwide-spacingcollagenﬁbrils
may reﬂect an excessive glycosylation in diabetes [11, 12].
Long-spacing collagen is also observed in the eyes from
patients with iridocorneal-endothelial syndrome, primary
open-angle glaucoma, age-related macular degeneration,
and Fuchs’ endothelial corneal dystrophy [9, 10, 32–34]. In
Fuchs’ corneal dystrophy, Descemet’s membrane thickens
abnormally; and many long-spacing collagen ﬁbrils are
formed in its posterior layer [10, 35]. A recent study showed
that Fuchs’ corneal dystrophy results from a mutation in
the gene encoding alpha 2 chain of type VIII collagen
[36, 37]. Lack of type VIII collagen results in dysgenesis
of the anterior segment of the eye, in which Descemet’s
membrane is markedly thinned [38]. Whereas human andYoshihiro Akimoto et al. 5
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Figure 3: Number of long-spacing collagen ﬁbrils per 10μm2 of
Descemet’s membrane in nondiabetic Wistar rat () and diabetic
GK rat () corneas. In the diabetic cornea, the long-spacing
collagen in Descemet’s increases more rapidly than in the normal
cornea with aging. Data are presented as the mean ± SD (n = 6).
∗P<. 05, ∗∗P<. 01.
mouse corneas have an anterior banded layer and a posterior
unbandedlayerintheirDescemet’smembrane,inthepresent
study these 2 layers could not be distinguished clearly in the
rat cornea. The long-spacing collagen tended to be localized
in the posterior side of Descemet’s membrane in the diabetic
ratcornea(Figure 2). This localization is consistent with that
observed in Fuch’s corneal dystrophy.
Diabetesinducesthedysfunctionofcornealendothelium
[39–42]. High glucose levels in diabetes cause the increase in
sorbitolaccumulation[43],advancedglycationendproducts
[44], and O-GlcNAc-modiﬁed proteins [3] in the cornea.
These changes may cause dysfunction of corneal endothelial
cells and induce the morphological change of Descemet’s
membrane as shown in the present study. Kaji et al. [44]
r e po rt edthatad van c edgl y cati o ne n dp r od uctsi nDesc e met ’ s
membrane may be responsible for the corneal endothelial
abnormalities in diabetes.
D-Phenylalanine derivative drug nateglinide and sul-
fonylurea drug glibenclamide are antidiabetic agents that
increase insulin secretion. When we examined the eﬀect
of nateglinide and glibenclamide on the morphological
c h a n g e si nD e s c e m e t ’ sm e m b r a n eo fG Kr a t s ,w ef o u n d
that the abnormal formation of the long-spacing collagen
was signiﬁcantly suppressed by the administration of either
nateglinideorglibenclamide(Figure 8).Theseresultssuggest
that control of postprandial hyperglycemia is essential to
prevent the abnormal formation of long-spacing collagen in
type-2 diabetes.
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Figure 4: Immunoﬂuorescence localization of type VIII collagen
(red color) in Descemet’s membrane of the cornea from 62-week-
old rats (a), (b) and Nomarsky microscopic images of the same
optical ﬁelds (c), (d). (a), (c) Wistar rat. (b), (d) GK rat. Green
color (SYBR-Green I) indicates the nuclei of endothelial cells. Dm:
Descemet’s membrane; En: endothelial cell; S: stroma. Scale bar:
10μm.
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Figure 5: Immunoelectron-microscopic detection of type VIII
collagen in Descemet’s membrane by the colloidal gold labeling
method. (a) In the cornea of a 15-week-old Wistar rat, the colloidal
gold label is distributed diﬀusely in the membrane. (b) In the
diabetic cornea of a 15-week-old GK rat, the gold marker is mainly
observedintheinternodalregionofthelong-spacingcollagen.Scale
bar, 100nm.
In the present study, glibenclamide treatment was
more eﬀective than nategelinide treatment (Figure 8). The
diﬀerent eﬀects of these two antidiabetic agents may be
due to their diﬀerent action mechanisms. Nateglinide and
glibenclamide display diﬀerent eﬀects on insulin secretion
in beta cell. Our previous study showed that decreased ﬁrst-
phase insulin release was partially recovered when GK rats
were treated with nateglinide, whereas no ﬁrst-phase release
occurred with glibenclamide treatment [25]. Nateglinide
administration reduced blood glucose 1 hour after feeding,
whereas glibenclamide administration reduced the blood
glucose level 2 and 3 hours after feeding [25]. Glibenclamide6 Experimental Diabetes Research
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Figure 6: Immunoelectron-microscopic localization of type VI
collagen in Descemet’s membrane by the colloidal gold labeling
method.Inbothnormalanddiabeticcorneas,thelabelwasdetected
mostly in the stroma, with little found in Descemet’s membrane
(a), (b) or in the long-spacing collagen (c), (d). Dm: Descemet’s
membrane; S: stroma. Scale bar: 100nm.
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Figure 7: Immunoelectron-microscopic localization of laminin in
Descemet’s membrane by the colloidal-gold labeling method. In
both the normal (a) and diabetic (b) cornea, the label was diﬀusely
distributed in the Descemet’s membrane but did not attach to the
long-spacing collagen. Scale bar: 100nm.
treatment is more eﬀective than nateglinide treatment in
the dysfunction of second-phase insulin release. The present
study suggests that glibenclamide treatment might be more
eﬀective in the inhibition of long-spacing collagen formation
by recovering second-phase insulin release.
In summary, more long-spacing collagen ﬁbrils were
observed in Descemet’s membrane of diabetic GK rats than
in the membrane of the nondiabetic Wistar rats. Type VIII
collagen was localized in the internodal region of the long-
spacing collagen. Further studies are needed to elucidate the
role of type VIII collagen in the formation of long-spacing
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Figure8:Inhibitionbyantidiabeticagentsoftheformationoflong-
spacing collagen in 15-week-old GK rats. The rats were admin-
istered methylcellulose alone (GK-Control), nateglinide (GK-
Nateglinide) or glibenclamide (GK-Glibenclamide) for 15 weeks,
which agents were suspended in methylcellulose. The number of
long-spacing collagen ﬁbrils in the Descemet’s membrane was
examinedbyelectronmicroscopy.Dataarepresentedasthemean ±
SD (n = 4). GK, GK rats. ∗P<. 05, ∗∗P<. 01.
collagen. Antidiabetic agents nateglinide and glibenclamide
signiﬁcantly suppressed the formation of the long-spacing
collagen in the diabetic rats. The long-spacing collagen of
the cornea would appear to be a useful indicator for studying
diabetic changes in the cornea and the eﬀect of antidiabetic
agents.
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